Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neural cell adhesion molecule 2 (NCAM2) is a member of the immunoglobulin superfamily and acts as a cell adhesion molecule predominantly expressed in the nervous system. It was originally identified as having high expression in the olfactory bulb, where it plays a key role in the organization and projection of primary olfactory axons. NCAM2 regulates neuronal morphogenesis, dendritic and axonal growth, synaptogenesis, and synaptic plasticity by modulating cytoskeletal dynamics and interacting with proteins such as MAP2, CaMKII, and the 14-3-3 family. These functions are essential for the proper formation and maintenance of neural circuits, memory, and learning. Altered expression or function of NCAM2 has been linked to several neurodevelopmental and neurodegenerative disorders, including autism spectrum disorder and Alzheimer's disease
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neural cell adhesion molecule 2 (NCAM2).